Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
Cancer
|
March 6, 2002
A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection
Aiden A Flynn, Alan J Green, R Barbara Pedley, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
May 18, 2016
Electrohydrodynamic encapsulation of cisplatin in poly (lactic-co-glycolic acid) nanoparticles for controlled drug delivery
Maryam Parhizkar, Philip J T Reardon, Jonathan C Knowles, et al.
Nuclear Medicine and Biology
|
October 31, 2009
Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake
Jason L J Dearling, Aiden A Flynn, Uzma Qureshi, et al.
International Journal of Nanomedicine
|
June 6, 2017
Electrohydrodynamic fabrication of core-shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment
Philip Jt Reardon, Maryam Parhizkar, Anthony H Harker, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2005
Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice
Ethaar El-Emir, Geoffrey M Boxer, Ingrid A Petrie, et al.
Journal of the American Chemical Society
|
December 1, 2012
A one-pot three-component radiochemical reaction for rapid assembly of 125I-labeled molecular probes
Ran Yan, Kerstin Sander, Eva Galante, et al.
Radiation Research
|
January 23, 2003
The nonuniformity of antibody distribution in the kidney and its influence on dosimetry
Aiden A Flynn, R Barbara Pedley, Alan J Green, et al.
International Journal of Oncology
|
January 5, 2007
Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-down
Katharine J Lankester, Ross J Maxwell, R Barbara Pedley, et al.
The Journal of Investigative Dermatology
|
February 1, 2013
Adrenomedullin haploinsufficiency predisposes to secondary lymphedema
Leonid L Nikitenko, Tatsuo Shimosawa, Stephen Henderson, et al.
Scientific Reports
|
March 15, 2016
Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20)
Natalie Burrows, Gaelle Cane, Mathew Robson, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
Cancer
|
March 6, 2002
A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection
Aiden A Flynn, Alan J Green, R Barbara Pedley, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
May 18, 2016
Electrohydrodynamic encapsulation of cisplatin in poly (lactic-co-glycolic acid) nanoparticles for controlled drug delivery
Maryam Parhizkar, Philip J T Reardon, Jonathan C Knowles, et al.
Nuclear Medicine and Biology
|
October 31, 2009
Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake
Jason L J Dearling, Aiden A Flynn, Uzma Qureshi, et al.
International Journal of Nanomedicine
|
June 6, 2017
Electrohydrodynamic fabrication of core-shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment
Philip Jt Reardon, Maryam Parhizkar, Anthony H Harker, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2005
Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice
Ethaar El-Emir, Geoffrey M Boxer, Ingrid A Petrie, et al.
Journal of the American Chemical Society
|
December 1, 2012
A one-pot three-component radiochemical reaction for rapid assembly of 125I-labeled molecular probes
Ran Yan, Kerstin Sander, Eva Galante, et al.
Radiation Research
|
January 23, 2003
The nonuniformity of antibody distribution in the kidney and its influence on dosimetry
Aiden A Flynn, R Barbara Pedley, Alan J Green, et al.
International Journal of Oncology
|
January 5, 2007
Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-down
Katharine J Lankester, Ross J Maxwell, R Barbara Pedley, et al.
The Journal of Investigative Dermatology
|
February 1, 2013
Adrenomedullin haploinsufficiency predisposes to secondary lymphedema
Leonid L Nikitenko, Tatsuo Shimosawa, Stephen Henderson, et al.
Scientific Reports
|
March 15, 2016
Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20)
Natalie Burrows, Gaelle Cane, Mathew Robson, et al.
Page
of 6